Skip to content

Outcome of ECMO and CRRT.

Outcome of ECMO and CRRT, Experience of Hospital University MED VI, Oujda, Morocco.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05033509
Enrollment
30
Registered
2021-09-02
Start date
2019-01-01
Completion date
2020-12-31
Last updated
2021-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and Renal Recovery, Incidence of CRRT With ECMO Therapy, Mortality

Keywords

COVID, AKI, CRRT, Ecmo

Brief summary

Background: Although acute kidney injury (AKI) is a frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), and the CRRT impact is widely studied. The incidence of simultaneous use of ECMO and CRRT remain unclear. Objective: The investigatore conducted this retrospective study to define the incidence of concomitant CRRT with ECMO therapy and to determine the overall impact of this strategy on patient outcomes such as mortality and renal recovery. Methods: The investigatore retrospectively analyzed data of patients of all ages, genders and ethnicities, admitted in the intensive care unit of Mohammed VI University Hospital, Oujda, Morocco, on a cumulative period of 2 years (January 2019 - December 2020). Were enrolled in the study patients who benefited from ECMO, and presented an acute kidney injury afterwards, using 'Microsoft Excel' as a software to utilize the information collected from the computerized patient database. 30 patients were included in the final study.

Interventions

OTHERsupervision the Kidney fonction on ECMO

patients who benefited from ECMO, and presented an acute kidney injury afterwards

Sponsors

Mohammed VI University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* benefited from ECMO . * presented an acute kidney injury afterwards

Exclusion criteria

* patients who developed AKI before benefitting from ECMO and/or missing data

Design outcomes

Primary

MeasureTime frameDescription
Ecmo and severe AKI requiring CRRTthrough study completion, an average of 24 mounths2 groups of patient was identified on this study : first ones are how developped aki and needek CRRT , 2nd are those who developped aki without CRRT

Countries

Morocco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026